Begum Shahina, Cabrera Eliazar Sabater, Restrepo Oscar Herrera, Burman Cindy, Sohn Woo-Yun, Kuylen Elise, Shah Hiral, Kocaata Zeki
GSK London, London, UK.
GSK Wavre, Wavre, Belgium.
Infect Dis Ther. 2024 Sep;13(9):2001-2015. doi: 10.1007/s40121-024-01017-x. Epub 2024 Jul 24.
Invasive meningococcal disease (IMD) is a severe and life-threatening disease. In the United States (US), vaccine coverage with MenACWY and MenB meningococcal vaccines is suboptimal among adolescents/young adults aged 16-23 years. A combined meningococcal vaccine (MenABCWY) could increase convenience (e.g., fewer injections) and improve coverage. The objective was to quantify preferences for hypothetical meningococcal vaccine profiles among adolescents/young adults and parents.
An online discrete choice experiment was conducted among 16- to 23-year-olds, and parents of 16- to 18-year-olds. Attributes (3 × 4) and levels (1 × 2) were based on the literature and focus groups. Participants made ten pair-wise forced trade-off choices, systematically varied using a D-optimal design. Random parameter logit quantified the relative importance of vaccination attributes and estimated the trade-offs. Differences in preferences by subgroups were assessed.
Totals of 300 adolescents and young adults (median age 20 years) and 300 parents (median age 46 years) completed the survey. Overall, 89.6% of 16- to 23-year-olds and 69.1% of parents preferred a simplified hypothetical meningococcal vaccination profile, e.g., with fewer injections (3 vs. 4) and fewer healthcare provider (HCP) visits (2-3 vs. 4). Having HCP advice and clear Centers for Disease Control and Prevention recommendations impacted vaccination choice, with both groups reporting high trust in HCP information (83.3% among 16- to 23-year-olds; 98.7% among parents). Barriers to vaccination included lack of HCP advice or awareness of meningococcal vaccines, and income level and out-of-pocket costs for parents.
Adolescents/young adults and parents demonstrated a significant preference for a meningococcal vaccine that is more convenient (such as combined MenABCWY). Parents' vaccination preferences differed by income level and out-of-pocket costs, suggesting financial barriers to vaccination may exist which could result in IMD prevention inequalities. Findings from this study provide important information to support patient-facing informed policy discussions. A simplified vaccination schedule and strong recommendation could help improve vaccine uptake, schedule compliance, disease prevention, and reduce inequalities in IMD risk and prevention. A graphical abstract is available with this article.
侵袭性脑膜炎球菌病(IMD)是一种严重的、危及生命的疾病。在美国,16至23岁青少年/年轻成年人中,A、C、W、Y群脑膜炎球菌疫苗(MenACWY)和B群脑膜炎球菌疫苗的接种覆盖率不理想。一种联合脑膜炎球菌疫苗(MenABCWY)可以增加便利性(例如,减少注射次数)并提高接种覆盖率。目的是量化青少年/年轻成年人及家长对假设的脑膜炎球菌疫苗接种方案的偏好。
对16至23岁的人群以及16至18岁人群的家长进行了一项在线离散选择实验。属性(3×4)和水平(1×2)基于文献和焦点小组。参与者做出十对成对的强制权衡选择,使用D最优设计进行系统变化。随机参数logit量化了疫苗接种属性的相对重要性并估计了权衡。评估了亚组之间偏好的差异。
共有300名青少年和年轻成年人(中位年龄20岁)以及300名家长(中位年龄46岁)完成了调查。总体而言,89.6%的16至23岁人群和69.1%的家长更喜欢简化的假设性脑膜炎球菌疫苗接种方案,例如注射次数更少(3次对4次)以及看医疗保健提供者(HCP)的次数更少(2至3次对4次)。获得HCP建议和明确的疾病控制与预防中心建议会影响疫苗接种选择,两组都表示对HCP信息高度信任(16至23岁人群中为83.3%;家长中为98.7%)。疫苗接种的障碍包括缺乏HCP建议或对脑膜炎球菌疫苗的认识,以及家长的收入水平和自付费用。
青少年/年轻成年人及家长对更方便的脑膜炎球菌疫苗(如联合MenABCWY)表现出明显偏好。家长的疫苗接种偏好因收入水平和自付费用而异,这表明可能存在疫苗接种的经济障碍,这可能导致可能导致IMD预防的不平等。本研究结果为支持面向患者的知情政策讨论提供了重要信息。简化的疫苗接种计划和有力的建议有助于提高疫苗接种率、计划依从性、疾病预防,并减少IMD风险和预防方面的不平等。本文配有图形摘要。